跳至主要内容
临床试验/NL-OMON56119
NL-OMON56119尚未招募不适用

Skin B cells in the progression from cutaneous lupus to systemic lupus - CLE to SLE

eids Universitair Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age >= 18 years.
  • 2. Diagnosis of CLE is made by dermatologist based on clinical features and
  • histopathological examination.
  • 3. In case of a SLE, this diagnosis is made by a rheumatologist based on 2019
  • ACR/EULAR classification criteria for SLE.
  • 4. Patients who have read, understood, and signed an informed consent document
  • related to this specific study.

排除标准

  • - Patients with any other dermatological of systemic disorder which would
  • interfere with the results, at the discretion of the investigator.
  • - Patients using topical corticosteroids and topical calcineurin inhibitors at
  • biopsy site within one week prior to enrolment.
  • - Patients who are or have been treated with specific B cell
  • depleting/modifying therapies (Rituximab, Belimumab, Cyclophosphamide)in 12
  • months prior to inclusion.

研究者

相似试验